Revolution Medicines
Price & Volume
Stats
See more52W Range | $29.17-$81.97 |
Market Cap | $15.6B |
Shares Short | 15M |
Financials
See moreRevenue (12 Mos) | $742,000 |
Revenue Growth (YoY) | -95.2% |
Gross Profit (12 Mos) | -$880.4M |
Diluted EPS | -$5.19 |
News
See moreYahoo Finance • 7 days ago
Here are the most and least likely M&A targets in biotech, according to Truist
Yahoo Finance • 12 days ago
Revolution Medicines Announces First Patient Randomized in the RASolute 304 Clinical Trial of Daraxonrasib in Resectable Pancreatic Ductal Adenocarcinoma Following Adjuvant Chemotherapy
Yahoo Finance • 2 months ago
Revolution Medicines outlines multiple Phase III trial launches and commercial buildout amid increased R&D investment
Yahoo Finance • 2 months ago
Revolution Medicines Reports Third Quarter 2025 Financial Results and Update on Corporate Progress
About
CEO | Dr. Mark A. Goldsmith M.D., Ph.D. |
Address | 700 Saginaw Drive, Redwood City, CA, United States, 94063 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 809 |
